Iovance Biotherapeutics I...

3.34
0.15 (4.70%)
At close: Apr 24, 2025, 3:59 PM
3.38
1.09%
After-hours: Apr 24, 2025, 07:59 PM EDT

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics reported an annual revenue of $164.07M, reflecting a 13698.99% growth. For the quarter ending December 31, 2024, Iovance Biotherapeutics generated $73.69M in revenue.
Revenue (ttm)
$164.07M
Revenue Growth
13698.99%
Price / Sales Ratio
13.07
Revenue / Employee
$195.79K
Employees
838
Market Cap
1.1B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 164.07M +13698.99%
Dec 31, 2023 1.19M +Infinity%
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.